157 related articles for article (PubMed ID: 26290632)
21. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability.
Suzuki T; Yoshida S; Hara H
Br J Nutr; 2008 Aug; 100(2):297-305. PubMed ID: 18346306
[TBL] [Abstract][Full Text] [Related]
22. Cephalexin inhibits N-formylated peptide transport and intestinal hyperpermeability in Caco2 cells.
Foster DR; Zheng X
J Pharm Pharm Sci; 2007; 10(3):299-310. PubMed ID: 17727793
[TBL] [Abstract][Full Text] [Related]
23. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells.
Jewell C; Cashman KD
Br J Nutr; 2003 May; 89(5):639-47. PubMed ID: 12720584
[TBL] [Abstract][Full Text] [Related]
24. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
[TBL] [Abstract][Full Text] [Related]
25. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells.
Gu L; Li N; Li Q; Zhang Q; Wang C; Zhu W; Li J
Fitoterapia; 2009 Jun; 80(4):241-8. PubMed ID: 19243699
[TBL] [Abstract][Full Text] [Related]
26. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
27. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
[TBL] [Abstract][Full Text] [Related]
28. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture.
Lindfors K; Blomqvist T; Juuti-Uusitalo K; Stenman S; Venäläinen J; Mäki M; Kaukinen K
Clin Exp Immunol; 2008 Jun; 152(3):552-8. PubMed ID: 18422736
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of intestinal model compound transport by DS-1, a modified Quillaja saponin.
Chao AC; Nguyen JV; Broughall M; Recchia J; Kensil CR; Daddona PE; Fix JA
J Pharm Sci; 1998 Nov; 87(11):1395-9. PubMed ID: 9811496
[TBL] [Abstract][Full Text] [Related]
30. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
31. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells.
Hwang D; Jo H; Hwang S; Kim JK; Kim IH; Lim YH
Biomed Pharmacother; 2017 Jan; 85():280-286. PubMed ID: 27876210
[TBL] [Abstract][Full Text] [Related]
32. The Pro-inflammatory Cytokine Interleukin-6 Regulates Nanoparticle Transport Across Model Follicle-Associated Epithelium Cells.
Miyake M; Ragnarsson E; Nakai D; Artursson P
J Pharm Sci; 2016 Jul; 105(7):2099-104. PubMed ID: 27262206
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of ethanol and hydrogen peroxide on barrier function and prostaglandin E2 release in differentiated Caco-2 cells: selective prevention by growth factors.
Catalioto RM; Festa C; Triolo A; Altamura M; Maggi CA; Giuliani S
J Pharm Sci; 2009 Feb; 98(2):713-27. PubMed ID: 18481313
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of ID331 Triticum monococcum gliadin on in vitro models of the intestinal epithelium.
Iacomino G; Di Stasio L; Fierro O; Picariello G; Venezia A; Gazza L; Ferranti P; Mamone G
Food Chem; 2016 Dec; 212():537-42. PubMed ID: 27374565
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of p38 mitogen-activated protein kinase attenuates butyrate-induced intestinal barrier impairment in a Caco-2 cell monolayer model.
Huang XZ; Li ZR; Zhu LB; Huang HY; Hou LL; Lin J
J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):264-9. PubMed ID: 24625969
[TBL] [Abstract][Full Text] [Related]
37. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.
Lei Q; Qiang F; Chao D; Di W; Guoqian Z; Bo Y; Lina Y
Int J Mol Med; 2014 Dec; 34(6):1629-39. PubMed ID: 25318952
[TBL] [Abstract][Full Text] [Related]
38. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
Moran GW; O'Neill C; McLaughlin JT
Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
40. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
Dimitrijevic D; Shaw AJ; Florence AT
J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
